Schlagwörter
DRUG COMPANY RESEARCH, J ENGEL, SYNTHETIC ROUTE DRUGS, PHARMACEUTICAL DRUG, PHARMA, FDA, DRUG INDEX, PHARMA GUIDE, MEDIKAMENTE, D REICHERT, AXEL KLEEMANN, API DATABASE, DRUG MANUFACTURERS, PHARMACEUTICAL R<, JÜRGEN ENGEL, GENERIC PHARMACEUTICAL MANUFACTURERS, PHARMA R<, DRUG DEVELOPTMENT, PHARMA COMPOUND, DRUG COMPOUND, PHARMAZEUTISCHE CHEMIE, PHARMACEUTICAL SUBSTANCES, <, JUERGEN ENGEL, APPROVED DRUG, PHARMACEUTICAL PATENTS, PHARMACEUTICAL RESEARCH, INTERMEDIATES, KLEEMANN ENGEL, CHEMISTRY API GUIDE, PATENTE, PHARMACEUTICAL INTERMEDIATES, SYNTHESIS OF DRUGS, DRUG SYNTHESIS, API COMPENDIUM, PHARMA RESEARCH, DIETMAR REICHERT, GENERIC DRUGS, DRUG COMPANY, DRUG COMPANIES, API GUIDE, INTERMEDIATE, PHARMA REFERENCE WORK, B KUTSCHER, APIS, PHARMACEUTICAL CHEMISTRY, BERNHARD KUTSCHER, DRUG GUIDE, MEDIZINALCHEMIE, MEDIKAMENTENSYNTHESE, PHARMACEUTICAL COMPOUND, PHARMAZEUTIKA, TRADE NAME API, FDA DRUGS, PHARMAZEUTISCHE WIRKSTOFFE, SYNTHESEKETTEN, API, GENERIKA, )>, (>, D, A KLEEMANN, MEDICINAL CHEMISTRY, GENERIC PHARMACEUTICALS, &, SYNTHETIC ROUTE, APPROVED, MEDIZINISCHE CHEMIE, API REFERENCE WORK, ACTIVE PHARMACEUTICAL INGREDIENT, PHARMACEUTICALS, PHARMACEUTICAL INGREDIENT